• Je něco špatně v tomto záznamu ?

Reduction of oxidative stress does not attenuate the development of angiotensin II-dependent hypertension in Ren-2 transgenic rats

L. Kopkan, Z. Husková, Z. Vaňourková, M. Thumová, P. Škaroupková, J. Malý, H.J. Kramer, P. Dvořák, L. Červenka

. 2009 ; 51 (2-3) : 175-181.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc11022998

Results of our previous studies have suggested that enhanced generation of superoxide (O2(-)) may contribute to the pathophysiology of hypertension in Ren-2 transgenic rats (TGR). The present study was performed to evaluate in TGR the effects of chronic treatment with the O2(-) scavenger tempol and the antioxidant apocynin on the development of hypertension. Systolic blood pressure (SBP) was monitored from 30 to 99 days of age in TGR and in normotensive Hannover Sprague-Dawley (HanSD) rats. At the end of the experiment, urinary protein and 8-isoprostane excretion were determined and angiotensin II (ANG II) and malondialdehyde (MDA) levels were measured in kidney and cardiac tissues. Cardiac hypertrophy was assessed as the ratio of left heart ventricle weight to tibia length (LVW/TL). Although tempol and apocynin treatment in TGR significantly decreased 8-isoprostane excretion and MAD tissue concentrations as compared with untreated TGR, it did not alter the course of SBP, LVW/TL ratio, proteinuria or ANG II levels that were enhanced as compared with HanSD rats. Our data suggest that the development of hypertension in TGR is clearly ANG II-dependent but the contribution of oxidative stress to the development of hypertension in this model appears to be negligible.

000      
03950naa 2200709 a 4500
001      
bmc11022998
003      
CZ-PrNML
005      
20121114111735.0
008      
110801s2009 xxu e Eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kopkan, Libor $7 xx0107287
245    10
$a Reduction of oxidative stress does not attenuate the development of angiotensin II-dependent hypertension in Ren-2 transgenic rats / $c L. Kopkan, Z. Husková, Z. Vaňourková, M. Thumová, P. Škaroupková, J. Malý, H.J. Kramer, P. Dvořák, L. Červenka
314    __
$a Department for Experimental Medicine, Institute for Clinical and Experimental Medicine, 1958/9 Videnska, CZ-140 21 Prague 4, Czech Republic.
520    9_
$a Results of our previous studies have suggested that enhanced generation of superoxide (O2(-)) may contribute to the pathophysiology of hypertension in Ren-2 transgenic rats (TGR). The present study was performed to evaluate in TGR the effects of chronic treatment with the O2(-) scavenger tempol and the antioxidant apocynin on the development of hypertension. Systolic blood pressure (SBP) was monitored from 30 to 99 days of age in TGR and in normotensive Hannover Sprague-Dawley (HanSD) rats. At the end of the experiment, urinary protein and 8-isoprostane excretion were determined and angiotensin II (ANG II) and malondialdehyde (MDA) levels were measured in kidney and cardiac tissues. Cardiac hypertrophy was assessed as the ratio of left heart ventricle weight to tibia length (LVW/TL). Although tempol and apocynin treatment in TGR significantly decreased 8-isoprostane excretion and MAD tissue concentrations as compared with untreated TGR, it did not alter the course of SBP, LVW/TL ratio, proteinuria or ANG II levels that were enhanced as compared with HanSD rats. Our data suggest that the development of hypertension in TGR is clearly ANG II-dependent but the contribution of oxidative stress to the development of hypertension in this model appears to be negligible.
590    __
$a bohemika - dle Pubmed
650    _2
$a acetofenony $x farmakologie $7 D000098
650    _2
$a analýza rozptylu $7 D000704
650    _2
$a angiotensin II $x analýza $x fyziologie $x krev $x moč $7 D000804
650    _2
$a zvířata $7 D000818
650    _2
$a antioxidancia $x farmakologie $7 D000975
650    _2
$a krevní tlak $7 D001794
650    _2
$a kardiomegalie $x komplikace $x prevence a kontrola $7 D006332
650    _2
$a cyklické N-oxidy $x farmakologie $7 D003497
650    _2
$a dinoprost $x analogy a deriváty $x moč $7 D015237
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a scavengery volných radikálů $x farmakologie $7 D016166
650    _2
$a hypertenze $x komplikace $x patofyziologie $x prevence a kontrola $7 D006973
650    _2
$a ledviny $x chemie $7 D007668
650    _2
$a nemoci ledvin $x komplikace $x prevence a kontrola $7 D007674
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a malondialdehyd $x analýza $7 D008315
650    _2
$a myokard $x chemie $7 D009206
650    _2
$a oxidační stres $x fyziologie $7 D018384
650    _2
$a proteinurie $7 D011507
650    _2
$a náhodné rozdělení $7 D011897
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Sprague-Dawley $7 D017207
650    _2
$a potkani transgenní $7 D055647
650    _2
$a renin $x genetika $7 D012083
650    _2
$a spinové značení $7 D013113
650    _2
$a časové faktory $7 D013997
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Husková, Zuzana, $d 1978- $7 xx0074206
700    1_
$a Vaňourková, Zdeňka, $d 1973- $7 xx0074217
700    1#
$a Thumová, Monika. $7 _AN037603
700    1_
$a Škaroupková, Petra $7 xx0117683
700    1_
$a Malý, Jan, $d 1943-2021 $7 nlk19990073523
700    1_
$a Kramer, Herbert J. $7 xx0085908
700    1#
$a Dvořák, Pavel. $7 xx0114163
700    1_
$a Červenka, Luděk, $d 1967- $7 xx0037105
773    0_
$t Vascular Pharmacology $w MED00008593 $g Roč. 51, č. 2-3 (2009), s. 175-181 $x 1537-1891
910    __
$a ABA008 $b x $y 2
990    __
$a 20110802094606 $b ABA008
991    __
$a 20121114111750 $b ABA008
999    __
$a ok $b bmc $g 881854 $s 732927
BAS    __
$a 3
BMC    __
$a 2009 $b 51 $c 2-3 $d 175-181 $m Vascular pharmacology $n Vascul Pharmacol $i 1537-1891 $x MED00008593
LZP    __
$a 2011-4B09/jvme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...